Bit of a bruising day with plenty of assumptions around where we are headed and at just north of 40c, most are very pessimistic.
Like most volatile days, the best outcome is not to panic sell and re-evaluate the true worth of ACR as the facts become clearer. Patent expiry, technological innovation and copying cloning and innovation are all part of the market.
We will have to wait and see how the dust settles and what emerges on the call on Thursday.
Ann: Acrux announces court ruling on Axiron patent families-ACR.AX, page-53
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
